A comparison of amino acid sequences of hepatitis B virus S gene in 46 children presenting various clinical features for immunoprophylaxis

被引：13

作者：

Miyake, Y

Oda, T

Li, R

Sugiyama, K

机构：

[1] Department of Pediatrics, Nagoya City Univ. Medical School

[2] Department of Pediatrics, Nagoya City Univ. Medical School, Mizuho-ku, Nagoya 467, Kawasumi-cho

来源：

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 180卷 / 03期

关键词：

hepatitis B virus; mother-to-child transmission; antibody escape mutant; S gene;

D O I：

10.1620/tjem.180.233

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We compared amino acid sequences of hepatitis B virus (HBV) S protein deduced from analyzed DNA sequence in 46 children who received immunoprophylaxis to prevent mother-to-child transmission of HBV. They were classified into 6 groups by their clinical features. The antibody escape mutants were found in 8 cases among 46 cases. We studied the difference in clinical features in these cases and speculated that 126 Ser or 140 Ser-strain may have a different behavior in relation to antibody to hepatitis B surface antigen from 126 Ban or 145 Arg-strain.

引用

页码：233 / 247

页数：15

共 21 条

[1] VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].

CARMAN, WF ;

ZANETTI, AR ;

KARAYIANNIS, P ;

WATERS, J ;

MANZILLO, G ;

TANZI, E ;

ZUCKERMAN, AJ ;

THOMAS, HC .

LANCET, 1990, 336 (8711) :325-329

[2] GLY145 TO ARG SUBSTITUTION IN HBS-ANTIGEN OF IMMUNE ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].

FUJII, H ;

MORIYAMA, K ;

SAKAMOTO, N ;

KONDO, T ;

YASUDA, K ;

HIRAIZUMI, Y ;

YAMAZAKI, M ;

SAKAKI, Y ;

OKOCHI, K ;

NAKAJIMA, E .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) :1152-1157

[3]

HARRISON TJ, 1994, VIRAL HEPATITIS LIVE, P248

[4] GLYCINE-TO-ARGININE SUBSTITUTION AT CODON-145 OF HBSAG IN 2 INFANTS BORN TO HEPATITIS-B E-ANTIGEN-POSITIVE CARRIER [J].

HINO, K ;

OKUDA, M ;

HASHIMOTO, O ;

ISHIKO, H ;

OKAZAKI, M ;

FUJII, K ;

HANADA, H ;

OKITA, K .

DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (03) :566-570

[5]

HOU JL, 1995, HEPATOLOGY, V21, P273, DOI 10.1002/hep.1840210202

[6]

HOWARD CR, 1988, VIRAL HEPATITIS LIVE, P1094

[7]

INAGAKI H, 1993, NAGOYA MED J, V38, P99

[8] ANTI-PRES2 NEUTRALIZES THE HEPATITIS-B VIRUS VARIANT WITH A VACCINE-ESCAPE MUTATION AT THE AMINO-ACID POSITION-126 OR POSITION-145 WITHIN THE S-GENE [J].

MACHIDA, A ;

OKAMOTO, H ;

TSUDA, F ;

TANAKA, T ;

DOMOTO, K ;

MISHIRO, S .

INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1994, 2 (03) :186-189

[9] GENETIC ALTERATIONS IN THE GENE ENCODING THE MAJOR HBSAG - DNA AND IMMUNOLOGICAL ANALYSIS OF RECURRENT HBSAG DERIVED FROM MONOCLONAL ANTIBODY-TREATED LIVER-TRANSPLANT PATIENTS [J].

MCMAHON, G ;

EHRLICH, PH ;

MOUSTAFA, ZA ;

MCCARTHY, LA ;

DOTTAVIO, D ;

TOLPIN, MD ;

NADLER, PI ;

OSTBERG, L .

HEPATOLOGY, 1992, 15 (05) :757-766

[10] IMMUNOSELECTED HEPATITIS-B VIRUS MUTANT [J].

MORIYAMA, K ;

NAKAJIMA, E ;

HOHJOH, H ;

ASAYAMA, R ;

OKOCHI, K .

LANCET, 1991, 337 (8733) :125-125

← 1 2 3 →